Related Experiment Video
Updated: Nov 10, 2025
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
SMARCB1/INI1-deficient tumors of adulthood
Nathaniel A Parker1, Ammar Al-Obaidi1, Jeremy M Deutsch2
1University of Kansas School of Medicine, 1010 N Kansas St, Wichita, KS, 67214, USA.
Abstract:
The SMARCB1/INI1 gene was first discovered in the mid-1990s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term "rhabdoid tumor" has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberrations in the SMARCB1/INI1 gene occur, the result can cause complete loss of expression, decreased expression, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the SMARCB1/INI1 gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail SMARCB1/INI1 expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors.
Insights
Loss of function mutations in the SMARCB1/INI1 gene cause aggressive rhabdoid tumors. Despite decades of research, limited literature details SMARCB1/INI1 expression in these challenging tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The SMARCB1/INI1 gene, discovered in the mid-1990s, is crucial for cell development.
- Loss-of-function mutations in SMARCB1/INI1 are linked to aggressive rhabdoid tumors.
- Rhabdoid tumors are increasingly defined by diminished SMARCB1/INI1 expression.
Purpose of the Study:
- To highlight the diagnostic challenges posed by SMARCB1/INI1-deficient tumors.
- To underscore the need for more reported cases detailing SMARCB1/INI1 expression.
- To emphasize the urgency for developing novel therapeutic strategies.
Main Methods:
- Review of existing literature on SMARCB1/INI1 gene and rhabdoid tumors.
- Analysis of the relationship between genetic aberrations and SMARCB1/INI1 expression levels.
- Discussion of diagnostic criteria and prognostic factors for these tumors.
Main Results:
- Genetic aberrations in SMARCB1/INI1 can lead to complete loss, decreased, or mosaic expression.
- SMARCB1/INI1-deficient tumors, predominantly sarcomas, exhibit diverse phenotypes complicating diagnosis.
- These aggressive tumors often have a poor prognosis with frequent disease relapse.
Conclusions:
- Accurate and timely diagnosis of rhabdoid tumors is imperative due to their aggressive nature.
- A significant gap exists in the literature regarding detailed SMARCB1/INI1 expression in rhabdoid tumors.
- Further research is essential to develop effective therapeutic strategies for patients.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...